Tony Ban, Vos Maaike J, Berkhof Johannes, Postma Tjeerd J, van Lingen Arthur, Heimans Jan J, Hoekstra Otto S
Department of Nuclear Medicine and PET Research bNeurology, VU University Medical Centre, Amsterdam, The Netherlands.
Nucl Med Commun. 2005 Jan;26(1):45-8. doi: 10.1097/00006231-200501000-00008.
201Tl SPECT is used successfully in the diagnosis of recurrent supratentorial glioma and in the evaluation of its response to chemotherapy. However, different methods are used to measure relative tracer uptake in tumour and background. The objective of this study was to assess the interobserver variability of such methods, and, if possible, to provide nomograms for data conversion.
Using baseline and follow-up SPECT scans from 20 patients with recurrent glioma treated with chemotherapy, three observers applied manual and semi-automatic ROI techniques to define activity in tumour (manual, semi-automatic) as well as in reference tissue (scalp, mirror, hemisphere).
All tumour ROI techniques had intra-class correlation coefficients (ICC) > or = 0.80 indicating almost perfect agreement. The main source of variation with the manual techniques was the tumour intensity; with the semi-automatic method, observer agreement was independent of the level of tumour activity. Agreement for background ROIs was also adequate, but the mirror technique tended to perform poorer at follow-up SPECT scans (ICC 0.68). Measurement of fractional change during treatment revealed no significant differences between observers for any of the investigated ROI methodology variants. Conversion of quantitative methods to measure fractional change was possible using linear regression analysis.
201Tl SPECT in recurrent glioma appears to be a robust method with acceptable interobserver variability. The clinical field in neuro-oncology should consider including 201Tl SPECT parameters in monitoring response to chemotherapy.
201铊单光子发射计算机断层扫描(201Tl SPECT)已成功用于复发性幕上胶质瘤的诊断及其化疗反应评估。然而,在测量肿瘤和背景中的相对示踪剂摄取时采用了不同方法。本研究的目的是评估这些方法在观察者间的变异性,并在可能的情况下提供数据转换的列线图。
利用20例接受化疗的复发性胶质瘤患者的基线和随访SPECT扫描,三名观察者应用手动和半自动感兴趣区(ROI)技术来确定肿瘤(手动、半自动)以及参考组织(头皮、镜像、半球)中的活性。
所有肿瘤ROI技术的组内相关系数(ICC)≥0.80,表明一致性几乎完美。手动技术的主要变异来源是肿瘤强度;半自动方法中,观察者间的一致性与肿瘤活性水平无关。背景ROI的一致性也足够,但镜像技术在随访SPECT扫描时表现往往较差(ICC 0.68)。治疗期间分数变化的测量显示,对于任何研究的ROI方法变体,观察者之间均无显著差异。使用线性回归分析可以将测量分数变化的定量方法进行转换。
复发性胶质瘤中的201Tl SPECT似乎是一种可靠的方法,观察者间变异性可接受。神经肿瘤学临床领域应考虑将201Tl SPECT参数纳入化疗反应监测中。